Taft partner Stephen R. Auten will be one of the featured presenters to kick off the 5^th Annual Paragraph IV Disputes Master Symposium, to be held Oct. 2-3 in Chicago. Auten will speak during the opening session “Paragraph IV Litigation Trends, Analysis and Future Predictions” at 8:15 a.m. on Oct. 2. Click here for more information on the conference.

Auten is head of Taft’s Pharmaceutical and Life Sciences Litigation practice. He is a widely recognized and seasoned attorney in Hatch-Waxman and biosimilar matters, including related patent litigation, and is followed by key industry leaders (brand and generic alike), law firms, analysts, educators and others on his LinkedIn blog “Hatch Waxman ANDA Litigation Forum,” which has more than 8,000 members worldwide. He currently represents clients primarily in the areas of Paragraph IV design strategies, Hatch-Waxman litigation and biosimilar market opportunities.